Abstract 4367492: Shared Circulating Proteins of Heart Failure and Dementia Risk: The Atherosclerosis Risk in Communities (ARIC) Study

F Frans Serpa (UT Southwestern Medical Center, Dallas, Texas, United States) F Fernando Giugni (UT Southwestern Medical Center, Dallas, Texas, United States) V Victoria Lamberson (Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX (A.D., V.L., F.R.G.).) Y Yimin Yang W Wendy Wang I Ihab Hajjar (UT Southwestern Medical Center, Dallas, Texas, United States) B Bing Yu (College of Chemistry and Materials Science, Guangdong Provincial Key Laboratory of Supramolecular Coordination Chemistry) J Joe Coresh (New York University Grossman School of Medicine, New York, New York, United States) T Thomas Mosley (UNIV MS MEDICAL CTR, Jackson, Mississippi, United States) K Keenan Walker (National Institute on Aging, Mount Airy, Maryland, United States) P Priya Palta (UNC Chapel Hill, Chapel Hill, North Carolina, United States) A A Sharrett (JOHN HOPKINS UNIV, Baltimore, Maryland, United States) A Amil Shah (University of Texas Southwestern Medical Center, Dallas (A.S.).)

Abstract

Introduction: Heart failure (HF) and dementia have overlapping risk factors and bidirectional epidemiologic associations, suggesting shared biological pathways. Limited data exist regarding plasma proteins reflecting the risk of both HF and dementia. Aim: Identify plasma proteins associated with the development of both incident HF and dementia. Methods: Among participants in the community-based Atherosclerosis Risk In Communities (ARIC) cohort study who were free of HF and dementia at study Visit 5 (2011–2013), we measured 4,955 plasma proteins using an aptamer-based assay (SomaScan). We used multivariable Cox proportional hazard regression models to assess associations of individual proteins with incident HF and with incident dementia at FDR significance. For models with HF as outcome, participants were censored at the time of incident dementia, and vice versa. Pathway enrichment was performed on candidate proteins using QIAGEN Ingenuity Pathway Analysis. Candidate proteins were further evaluated for cross-sectional associations with echocardiographic and brain MRI measures using multivariable linear models. All models were adjusted for demographics, comorbidities, education, and APOE4 genotype. Results: Among 3,259 HF- and dementia-free participants (age 74±4 years;60% female;17% self-reported Black race), 433 incident HF events occurred over a median follow-up of 10 [IQR 8–11] years, and 579 incident dementia events occurred over 9 [IQR 8–10] years. We identified 345 proteins associated with incident HF and 66 associated with incident dementia, with 36 associated with both conditions (Figure). These proteins enriched for pathways related to inflammation, remodeling, and metabolic stress. Of these 36 proteins, 19 were associated with HFpEF and HFrEF, 16 with HFpEF only, and 1 with HFrEF only. In addition, 13 proteins were associated with lower temporal lobe integrity, while only 1 was associated with higher white matter hyperintensities. All were associated with subclinical LV remodeling and worse diastolic function while half were associated with worse LV systolic function. Conclusion: We identified circulating proteins reflecting shared risk for development of both HF and dementia that enriched for biological pathways reflecting inflammation, remodeling and metabolic stress. These proteins were more consistently associated with HFpEF than HFrEF, and diastolic compared to systolic dysfunction, suggesting these two conditions of late-life share common pathways.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (13)

F

Frans Serpa

UT Southwestern Medical Center, Dallas, Texas, United States

F

Fernando Giugni

UT Southwestern Medical Center, Dallas, Texas, United States

V

Victoria Lamberson

Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX (A.D., V.L., F.R.G.).

Y

Yimin Yang

W

Wendy Wang

I

Ihab Hajjar

UT Southwestern Medical Center, Dallas, Texas, United States

B

Bing Yu

College of Chemistry and Materials Science, Guangdong Provincial Key Laboratory of Supramolecular Coordination Chemistry

J

Joe Coresh

New York University Grossman School of Medicine, New York, New York, United States

T

Thomas Mosley

UNIV MS MEDICAL CTR, Jackson, Mississippi, United States

K

Keenan Walker

National Institute on Aging, Mount Airy, Maryland, United States

P

Priya Palta

UNC Chapel Hill, Chapel Hill, North Carolina, United States

A

A Sharrett

JOHN HOPKINS UNIV, Baltimore, Maryland, United States

A

Amil Shah

University of Texas Southwestern Medical Center, Dallas (A.S.).